VIR
#2049
Vir Biotechnology, Inc. - Common Stock
11.3 1 USD
+0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+2.08%
Monthly Change
+27.94%
6 month change
+27.80%
Year Change
+89.13%
Previous Close
11.0 8
Open
11.3 1
Low
11.3 1
High
11.3 1
Volume
147
Financials
- Market Capitalization 1.91 B
- Employee 367
- Founded 2016
- CEO Marianne De Backer
- Website www.vir.bio
- Headquarter Delaware, United States
- FIGI BBG00H2QQ8T5
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.91
Price to sales ratio
12.18
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2004 |  AGIO Agios Pharmaceuticals, Inc. - Common Stock | 34.28 USD | +0.85% | +1.48% | -4.33% | -21.00% | 2.05 B USD | ||
| 2040 |  TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.96 USD | -1.00% | -3.56% | +10.17% | +109.86% | 1.94 B USD | ||
| 2055 |  IMCR Immunocore Holdings plc - American Depositary Shares | 36.75 USD | -1.00% | +0.14% | +10.00% | +9.77% | 1.89 B USD | ||
| 2056 |  SEPN Septerna, Inc. - Common Stock | 40.47 USD | +0.55% | -2.34% | +19.13% | +83.87% | 1.89 B USD |
Frequently asked questions about Vir Biotechnology, Inc. Common Stock
What is the Vir Biotechnology, Inc. Common Stock stock price today?
The current price of Vir Biotechnology, Inc. Common Stock (VIR) is 11.31. Over the past 24 hours, the stock has changed by +2.08%. Follow the VIR chart for real-time price dynamics.
What is the stock ticker of Vir Biotechnology, Inc. Common Stock?
Vir Biotechnology, Inc. Common Stock trades under the ticker VIR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Vir Biotechnology, Inc. Common Stock stock going up?
VIR has changed by +21.48% over the last week, +27.94% over the last month, and +89.13% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Vir Biotechnology, Inc. Common Stock?
Vir Biotechnology, Inc. Common Stock currently has a market capitalization of 1.91 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
Does Vir Biotechnology, Inc. Common Stock release financial reports?
Yes. You can track Vir Biotechnology, Inc. Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What were Vir Biotechnology, Inc. Common Stock earnings last quarter?
Last quarter, Vir Biotechnology, Inc. Common Stock reported earnings of 0.48 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Vir Biotechnology, Inc. Common Stock revenue for the last quarter?
Vir Biotechnology, Inc. Common Stock reported quarterly revenue of 238.95 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Vir Biotechnology, Inc. Common Stock net income for the last quarter?
Vir Biotechnology, Inc. Common Stock reported net income of 80.08 M for the last quarter. The previous quarter showed -125.69 M, which means net income changed by +163.71%.
How many employees does Vir Biotechnology, Inc. Common Stock have?
As of the latest available data, Vir Biotechnology, Inc. Common Stock has 367 employees. Workforce size can provide additional context about the company's scale and operations.
What is Vir Biotechnology, Inc. Common Stock EBITDA?
Vir Biotechnology, Inc. Common Stock EBITDA is 76.27 M, and its EBITDA margin is 31.92%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Vir Biotechnology, Inc. Common Stock stock?
You can buy Vir Biotechnology, Inc. Common Stock (VIR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Vir Biotechnology, Inc. Common Stock stock?
Investing in Vir Biotechnology, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VIR chart and related analysis on metatrader.com as part of your research.